@annexinpharma.com
Annexin Pharmaceuticals AB (publ) är ett världsledande bioteknikföretag inom Annexin A5-området, för behandling av olika hjärt- och kärlsjukdomar, som i dag är den vanligaste dödsorsaken.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Annexin Pharmaceuticals AB (publ) is a renowned biotechnology company specializing in the Annexin A5 domain, focusing on the treatment of various cardiovascular diseases, which are currently the leading cause of death. With a mission to empower the body to fight disease, Annexin Pharmaceuticals develops innovative products and services centered around heart and vascular disorders. The company's leading medicine, ANXV, is a human recombinant protein that leverages Annexin A5 to provide acute treatment for patients with cardiovascular diseases, addressing damage and inflammation in blood vessels.
ANXV not only protects and repairs blood vessels but also counteracts inflammation. Research studies have demonstrated the protective and reparative role of Annexin A5, mitigating unwanted inflammation, rupture of atherosclerotic plaques, and potential complications like heart attack, stroke, and poor leg circulation. Underpinned by a strong commitment to scientific advancement, Annexin Pharmaceuticals conducts extensive research and development activities to harness the full potential of Annexin A5 and its therapeutic applications.
By focusing on diseases of utmost importance, such as heart and vascular disorders, Annexin Pharmaceuticals aims to revolutionize the field of cardiovascular medicine. Note: The provided text is partially in Swedish and English
Company Type
Public Company
Company Size
2-10
Year Founded
2014
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online